
Robert A. Zeman
Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1326 |
| Issued Applications | 557 |
| Pending Applications | 268 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14210719
[patent_doc_number] => 20190117744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
[patent_app_type] => utility
[patent_app_number] => 16/207655
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16207655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/207655 | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | Dec 2, 2018 | Issued |
Array
(
[id] => 17154162
[patent_doc_number] => 20210315213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITION FOR BIOLOGICAL CONTROL OF PHYTONEMATODES
[patent_app_type] => utility
[patent_app_number] => 17/266780
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266780 | COMPOSITION FOR BIOLOGICAL CONTROL OF PHYTONEMATODES | Nov 13, 2018 | Abandoned |
Array
(
[id] => 14338807
[patent_doc_number] => 20190151376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA
[patent_app_type] => utility
[patent_app_number] => 16/175299
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175299 | TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA | Oct 29, 2018 | Abandoned |
Array
(
[id] => 18084378
[patent_doc_number] => 11534485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Vaccine used for preventing toxoplasma gondii infection and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 17/253798
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 4433
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253798 | Vaccine used for preventing toxoplasma gondii infection and preparation method therefor | Oct 21, 2018 | Issued |
Array
(
[id] => 13867601
[patent_doc_number] => 20190030141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING FUNGAL AND BACTERIAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/157248
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157248 | COMPOSITIONS AND METHODS FOR TREATING FUNGAL AND BACTERIAL PATHOGENS | Oct 10, 2018 | Abandoned |
Array
(
[id] => 13901867
[patent_doc_number] => 20190040138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Anti-PD-1 monoclonal antibody
[patent_app_type] => utility
[patent_app_number] => 16/146925
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16146925
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/146925 | Anti-PD-1 monoclonal antibody | Sep 27, 2018 | Issued |
Array
(
[id] => 17256805
[patent_doc_number] => 20210369790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESPONSIVE TO OBESITY TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 16/756458
[patent_app_country] => US
[patent_app_date] => 2018-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756458 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESPONSIVE TO OBESITY TREATMENTS | Sep 15, 2018 | Pending |
Array
(
[id] => 14685021
[patent_doc_number] => 20190241625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Streptococcus suis Vaccines to Protect Against Reproductive, Nursery-Age, and Growing Pig Diseases and Methods of Making and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/118857
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118857
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118857 | None | Aug 30, 2018 | Issued |
Array
(
[id] => 16899001
[patent_doc_number] => 20210177917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/642340
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642340 | MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY | Aug 30, 2018 | Abandoned |
Array
(
[id] => 13901807
[patent_doc_number] => 20190040108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => VACCINE AND METHODS FOR DETECTING AND PREVENTING FILARIASIS
[patent_app_type] => utility
[patent_app_number] => 16/116203
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116203 | Vaccine and methods for detecting and preventing filariasis | Aug 28, 2018 | Issued |
Array
(
[id] => 16190785
[patent_doc_number] => 20200231634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => TOPICAL COMPOSITIONS AND USES
[patent_app_type] => utility
[patent_app_number] => 16/632299
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632299 | Topical compositions and uses | Jul 19, 2018 | Issued |
Array
(
[id] => 13519569
[patent_doc_number] => 20180311327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => AQUAPORIN 2 PROTECTS CATTLE FROM TICKS AND TICK-BORNE PARASITES
[patent_app_type] => utility
[patent_app_number] => 16/034042
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034042 | Aquaporin 2 protects cattle from ticks and tick-borne parasites | Jul 11, 2018 | Issued |
Array
(
[id] => 15899069
[patent_doc_number] => 20200149053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/619010
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 221200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -80
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619010 | MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS | Jul 10, 2018 | Abandoned |
Array
(
[id] => 17620170
[patent_doc_number] => 11339208
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-24
[patent_title] => Camelidae single-domain antibodies against
[patent_app_type] => utility
[patent_app_number] => 16/023723
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 37
[patent_no_of_words] => 9496
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023723 | Camelidae single-domain antibodies against | Jun 28, 2018 | Issued |
Array
(
[id] => 16837943
[patent_doc_number] => 20210145955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE
[patent_app_type] => utility
[patent_app_number] => 16/624530
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624530
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624530 | CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE | Jun 25, 2018 | Abandoned |
Array
(
[id] => 15869063
[patent_doc_number] => 20200141935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PREGNANCY
[patent_app_type] => utility
[patent_app_number] => 16/624998
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624998 | SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PREGNANCY | Jun 24, 2018 | Abandoned |
Array
(
[id] => 17046015
[patent_doc_number] => 11099188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => ROS kinase in lung cancer
[patent_app_type] => utility
[patent_app_number] => 15/994165
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 30
[patent_no_of_words] => 34126
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994165 | ROS kinase in lung cancer | May 30, 2018 | Issued |
Array
(
[id] => 16236793
[patent_doc_number] => 20200254027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => LYOPHILIZED COMPOSITIONS COMPRISING FECAL MICROBE-BASED THERAPEUTIC AGENTS AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/616846
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616846 | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same | May 24, 2018 | Issued |
Array
(
[id] => 16086921
[patent_doc_number] => 20200197447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => BACTERIOTHERAPY BASED ON BACTERIAL COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/615355
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615355 | BACTERIOTHERAPY BASED ON BACTERIAL COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | May 22, 2018 | Abandoned |
Array
(
[id] => 18171754
[patent_doc_number] => 11571447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Composition for preventing, ameliorating or treating metabolic syndrome
[patent_app_type] => utility
[patent_app_number] => 16/616000
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6294
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616000 | Composition for preventing, ameliorating or treating metabolic syndrome | May 22, 2018 | Issued |